نتایج جستجو برای: xenograft model

تعداد نتایج: 2117815  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Arman Jahangiri Michael De Lay Liane M Miller W Shawn Carbonell Yu-Long Hu Kan Lu Maxwell W Tom Jesse Paquette Taku A Tokuyasu Sean Tsao Roxanne Marshall Arie Perry Kirsten M Bjorgan Myriam M Chaumeil Sabrina M Ronen Gabriele Bergers Manish K Aghi

PURPOSE To identify mediators of glioblastoma antiangiogenic therapy resistance and target these mediators in xenografts. EXPERIMENTAL DESIGN We conducted microarray analysis comparing bevacizumab-resistant glioblastomas (BRG) with pretreatment tumors from the same patients. We established novel xenograft models of antiangiogenic therapy resistance to target candidate resistance mediator(s). ...

Journal: :Molecular cancer therapeutics 2012
Judy Quiju Shi Kerri Lasky Vaishali Shinde Bradley Stringer Mark G Qian Debra Liao Ray Liu Denise Driscoll Michelle Tighe Nestor Benjamin S Amidon Youlan Rao Matt O Duffey Mark G Manfredi Tricia J Vos Natalie D' Amore Marc L Hyer

Diffuse large B-cell lymphoma (DLBCL) is the most common of the non-Hodgkin lymphomas, accounting for up to 30% of all newly diagnosed lymphoma cases. Current treatment options for this disease are effective, but not always curative; therefore, experimental therapies continue to be investigated. We have discovered an experimental, potent, and selective small-molecule inhibitor of PLK1, MLN0905,...

2016
Yanfen Cui Caiyuan Zhang Ran Luo Huanhuan Liu Zhongyang Zhang Tianyong Xu Yong Zhang Dengbin Wang

PURPOSE Arginine-glycine-aspartic acid (RGD)-based nanoprobes allow specific imaging of integrin αvβ3, a protein overexpressed during angiogenesis. Therefore, this study applied a novel RGD-coupled, polyacrylic acid (PAA)-coated ultrasmall superparamagnetic iron oxide (USPIO) (referred to as RGD-PAA-USPIO) in order to detect tumor angiogenesis and assess the early response to antiangiogenic tre...

Journal: :Anticancer research 2015
Jason W Kesinger Meghna Mehta Megan R Lerner Daniel J Brackett Robert W Brueggemeier Pui-Kui Li J Thomas Pento

BACKGROUND Keratinocyte growth factor (KGF)/KGF receptor (KGFR) signaling produces a rapid increase in the progression of breast cancer. Molecular modeling was used to create a group of KGFR-selective kinase inhibitors (TKI). Compound L-27 is a potent and selective KGFR TKI. The present study examined the oncolytic potential of L-27 using a breast cancer xenograft model. MATERIALS AND METHODS...

Objective(s): Gastric cancer is the third leading cause of cancer-related death worldwide. The overall survival rate of patients is poor because gastric cancers are usually diagnosed at the late stages. Therefore, further research is needed and appropriate research tools are required to develop novel therapeutic approaches.Materials and Methods: Eight female athymic nude mice with a C57BL/6 bac...

2017
Yiming Qi Yu Hu Hua Yang Rongyuan Zhuang Yingyong Hou Hanxing Tong Yi Feng Yuan Huang Quan Jiang Qunsheng Ji Qingyang Gu Zhixiang Zhang Xuzhen Tang Weiqi Lu Yuhong Zhou

Myxoid and round cell liposarcoma (MRCL) is a common type of soft tissue sarcoma. The lack of patient-derived tumor xenograft models that are highly consistent with human tumors has limited the drug experiments for this disease. Hence, we aimed to develop and validate a patient-derived tumor xenograft model of MRCL. A tumor sample from a patient with MRCL was implanted subcutaneously in an immu...

2017
Yi Zhu Minjie Wang Xu Zhao Lei Zhang Yigao Wu Bangqi Wang Weilie Hu

Adrenocortical carcinoma (ACC) is a rare, but aggressive endocrine malignancy with a generally poor clinical outcome. There is no effective therapy for advanced and metastatic ACC. In our study, we found that an existing drug (rottlerin) exerted its tumour-suppressive function in ACC. Specifically, rottlerin inhibited cellular proliferation of ACC cell lines (NCI-H295R and SW-13) in a dose- and...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید